← Back to patent-cliff list
Sodium ferric gluconate complex
Tier C — Watch / tradeSodium ferric gluconate complex
Allergan
Originator
1999
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Brand：Ferrlecit
Indications (approved)：Iron deficiency anaemia
Regional status
US
Approved
1999-02-18
EU
No progress
2003-12-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Sodium ferric gluconate complex?
Approved indications include: Iron deficiency anaemia.
When does the Sodium ferric gluconate complex patent expire?
No public expiry year is available for Sodium ferric gluconate complex yet; this page updates once verified.
How do I get a quote for Sodium ferric gluconate complex intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04